NEW YORK (GenomeWeb News) – Illumina and Agilent have entered into a non-exclusive co-marketing agreement focused on researchers conducting targeted resequencing.

The firms jointly announced today that they will co-market Agilent's SureSelect Target Enrichment System with Illumina's Genome Analyzer. They said the combination will provide researchers with a method for efficiently resequencing specific regions of interest in the genome and will enable researchers to conduct studies that otherwise would not be feasible.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

In Science this week: self-assembly of DNA components in solution, and more.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.